Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
If you’re new to crypto, you’ll want a clear starting point and safe approach. This intro explains which crypto to buy first and how to assess risk without overwhelming you.
27,491 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Meta Platforms is pouring billions into AI infrastructure. This piece breaks down why that spending could pay off for...
As housing markets tighten, brokerages race to deploy must-have real estate marketing tools in 2026. This story break...
As the S&P 500 earnings season begins, investors focus on underappreciated sectors that could produce big surprises. ...
Microsoft leans on three strategic ties—OpenAI, hardware collaboration with AMD, and Copilot enterprise adoption—to s...
A Supreme Court ruling blocks Trump’s emergency tariffs, leaving executives silent as refunds, labor concerns, and ma...
CrowdStrike holds steady Wednesday in early trading after strong quarterly results, while GitLab slides on a dimmer g...
NVIDIA lands a major China AI chip deal, signaling a powerful push into the region’s AI buildout. Yet a 25% tariff th...
Piper Sandler moved to downgrade its Fastly target after Q1 FY2026 showed slowing core delivery volumes. The stock dr...
A U.S.-listed ETF now prioritizes balance-sheet quality in developed markets, offering overseas exposure without weak...
Tensions with Iran push costs beyond official tallies, raising inflation risk and weighing on markets. This report br...
Stylecraft Builders maintains momentum in Texas by deploying a precise, micro approach to margins and pace. With 2025...